Strong Same-Store NOI Growth
Total portfolio same-store NOI grew 21.6% year over year in the fourth quarter, with full year 2024 same-store NOI growth at 17.7% compared to 2023.
Trilogy Segment Performance
Trilogy segment's same-store NOI grew by 28% year over year in Q4 2024, and 23.8% for the full year. This segment is noted for its robust health outcomes and financial results.
Significant Reduction in Leverage
Net debt to adjusted EBITDA decreased from 8.5 times at the end of 2023 to 4.3 times at the end of 2024, enhancing financial flexibility.
Successful Capital Allocation Strategy
Invested over $650 million in external growth in managed long-term care segments in 2024 and announced new investments for 2025, including two new shop assets and several Trilogy development projects.
Positive Outlook for 2025
Guidance for 2025 includes 7% to 10% same-store NOI growth and $1.56 to $1.60 NFFO per share, anticipating double-digit NFFO per share growth.